CURRENT ISSUE [Volume 4, Issue 2, 2019]

  • Siponimod: A new approved oral drug to treat multiple sclerosis
    Siponimod: A new approved oral drug to treat multiple sclerosis

    2019, Volume 4, Issue 2 [Download Full PDF]

  • Patients and health care professionals alert: Ranitidine may cause cancer
    Patients and health care professionals alert: Ranitidine may cause cancer

    2019, Volume 4, Issue 2 [Download Full PDF]

  • Angiotensin II receptor blockers with NDMA impurities: Patients and health care professionals alert
    Angiotensin II receptor blockers with NDMA impurities: Patients and health care professionals alert

    2019, Volume 4, Issue 2 [Download Full PDF]

  • Nourianz: A new add-on drug to treat off episodes in adults with Parkinson’s disease
    Nourianz: A new add-on drug to treat off episodes in adults with Parkinson’s disease

    2019, Volume 4, Issue 2 [Download Full PDF]